
### [NCIT:C9336](http://purl.obolibrary.org/obo/NCIT_C9336)
**Label:** Nasal Cavity Carcinoma

**Subclasses:** [NCIT:C27389](http://purl.obolibrary.org/obo/NCIT_C27389) (Carcinoma Arising in Nasal Papillomatosis), [NCIT:C8192](http://purl.obolibrary.org/obo/NCIT_C8192) (Nasal Cavity Squamous Cell Carcinoma), [NCIT:C4589](http://purl.obolibrary.org/obo/NCIT_C4589) (Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8), [NCIT:C6013](http://purl.obolibrary.org/obo/NCIT_C6013) (Stage I Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C54285](http://purl.obolibrary.org/obo/NCIT_C54285) (Keratinizing Nasal Cavity Squamous Cell Carcinoma), [NCIT:C6012](http://purl.obolibrary.org/obo/NCIT_C6012) (Stage II Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C6015](http://purl.obolibrary.org/obo/NCIT_C6015) (Nasal Cavity Adenocarcinoma), [NCIT:C6011](http://purl.obolibrary.org/obo/NCIT_C6011) (Stage III Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C118817](http://purl.obolibrary.org/obo/NCIT_C118817) (Childhood Nasal Cavity Carcinoma), [NCIT:C6010](http://purl.obolibrary.org/obo/NCIT_C6010) (Stage IV Nasal Cavity Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C54201](http://purl.obolibrary.org/obo/NCIT_C54201) (Exophytic Papillary Lesion) 55.00%
- [NCIT:C45978](http://purl.obolibrary.org/obo/NCIT_C45978) (Fungating Mass) 55.00%
- [NCIT:C35520](http://purl.obolibrary.org/obo/NCIT_C35520) (Nasal Mass) 55.00%
- [NCIT:C26766](http://purl.obolibrary.org/obo/NCIT_C26766) (Epistaxis) 55.00%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C122604](http://purl.obolibrary.org/obo/NCIT_C122604) (Infantile Lesion))) 55.00%
- Thing 52.57%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 43.84%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 40.36%
- [NCIT:C60644](http://purl.obolibrary.org/obo/NCIT_C60644) (Childhood Lesion) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 40.36%


